| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Immunome, Inc. (IMNM) have been net sellers, shedding 132,752 shares worth roughly $3.5M on balance.
Classified under Biotechnology (Health Care sector), IMNM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 870.7K | - | - | |
| Dir | 341.1K | $7.04M | - | |
| CFO | 101.3K | - | - | |
| Dir | 92.2K | $2.51M | - | |
| Other | 81.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Higgins Jack | Chief Scientific Officer | Sale+OE10b5-1 | 13,200 | $25.32 | $334,224.00 | -16.9% | - | - | |
| Aug 12, 2026 | Barchas Isaac56 | Director | Sell10b5-1 | 83,464 | $26.35 | $2,198,909.68 | -47.5% | - | - | |
| Aug 7, 2026 | Barchas Isaac56 | Director | Sell10b5-1 | 36,088 | $26.06 | $940,453.28 | -33.3% | - | - | |
| Aug 4, 2026 | Horn Kinney87 | Chief Business Officer | Sale+OE10b5-1 | 90,616 | $25.09 | $2,273,555.44 | - | - | - | |
| Jul 7, 2026 | Horn Kinney87 | Chief Business Officer | Sale+OE10b5-1 | 1,092 | $25.00 | $27,300.00 | - | -13.2% | - | |
| Jul 7, 2026 | Barchas Isaac56 | Director | Sell10b5-1 | 100,000 | $24.13 | $2,412,521.54 | -48.0% | -13.2% | - | |
| Jul 2, 2026 | Lechleider Robert76 | Chief Medical Officer | Sale+OE10b5-1 | 55,000 | $22.62 | $1,244,330.62 | -77.7% | -8.9% | - | |
| Jul 2, 2026 | Barchas Isaac56 | Director | Sell10b5-1 | 201,050 | $21.85 | $4,393,024.30 | -28.0% | -8.9% | - | |
| Jun 25, 2026 | Lechleider Robert76 | Chief Medical Officer | Sale+OE10b5-1 | 55,000 | $19.85 | $1,091,662.00 | -77.7% | +24.9% | - | |
| Jun 15, 2026 | Rosett Max65 | Chief Financial Officer | Sale+OE10b5-1 | 60,000 | $18.23 | $1,093,800.00 | -52.6% | +35.9% | - |